InMed Pharmaceuticals: InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Free Report) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 18,900 shares, a growth of 339.5% from the October 15th total of 4,300 shares. Based on an average daily volume of 1,700,000 shares, the days-to-cover ratio […]
InMed Pharmaceuticals Inc. , a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced that an abstract.
InMed Pharmaceuticals: InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.